doug sandler, you know, 45% since the haines bottom. over the past two weeks, the u.s. markets are up, i think, give or take 11%, 12%. it does go to show you just because it's up doesn't mean it won't keep going up. but do you think you can really play catch-up with biotech? >> biotech has been a lagger, although it's up, everything is up. look at the market, a lot of places. fuel is uncomfortable to chase. particularly technology which i think year to date we're up somewhere around 30% to 40%. biotech has been a real lagger. the interesting thing is in my opinion, i think biotech and technology tend to be pretty interchangeable, meaning in the end, you know, both of them tend to print the similar returns when tech's hot, biotech tends to be hot. you have this period of time here where the alligator jaws essentially have opened up, meaning technology has had a good run. biotech has lagged. i think that creates a catalyst for catch-up. i think there's good explanation around why that catalyst is starting to ignite right now. >> mike huckman, what would be a catalyst for